ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia

Lu, Bingli; Wang, Lingyun*; Tang, Hao; Cao, Derong
Journal of Materials Chemistry B2023-5-31DOI: 10.1039/d3tb00545c
9被引9阅读
引用收藏
分享

摘要

Photodynamic therapy (PDT) with an oxygen-dependent character is a noninvasive therapeutic method for cancer treatment. However, its clinical therapeutic effect is greatly restricted by tumor hypoxia. What's more, both PDT-mediated oxygen consumption and microvascular damage aggravate tumor hypoxia, thus, further impeding therapeutic outcomes. Compared to type II PDT with high oxygen dependence and high oxygen consumption, type I PDT with less oxygen consumption exhibits great potential to overcome the vicious hypoxic plight in solid tumors. Type I photosensitizers (PSs) are significantly important for determining the therapeutic efficacy of PDT, which performs an electron transfer photochemical reaction with the surrounding oxygen/substrates to generate highly cytotoxic free radicals such as superoxide radicals (O-2(-)) as type I ROS. In particular, the primary precursor (O-2(-)) would progressively undergo a superoxide dismutase (SOD)-mediated disproportionation reaction and a Haber-Weiss/Fenton reaction, yielding higher cytotoxic species (OH) with better anticancer effects. As a result, developing high-performance type I PSs to treat hypoxic tumors has become more and more important and urgent. Herein, the latest progress of organic type I PSs (such as AIE-active cationic/neutral PSs, cationic/neutral PSs, polymer-based PSs and supramolecular self-assembled PSs) for monotherapy or synergistic therapeutic modalities is summarized. The molecular design principles and strategies (donor-acceptor system, anion-pi(+) incorporation, polymerization and cationization) are highlighted. Furthermore, the future challenges and prospects of type I PSs in hypoxia-overcoming PDT are proposed.

学科与关键词

关键词
AGGREGATION-INDUCED EMISSIONCANCER-CELLSDESIGNPDTSTRATEGIESOXIDE
相关
加载中…
  • Recent advances in aggregation-induced emission-active type I photosensitizers with near-infrared fluorescence: From materials design to therapeutic platform fabrication
    Xie, Yili; Li, Zhijia; Zhao, Chunhui*; Lv, Ruizhi; Li, Yan; Zhang, Zhihong; Teng, Muzhou*; Wan, Qing*Luminescence : the journal of biological and chemical luminescence , 2024, 39(1).
  • Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress
    Zhuang, Zeyan; Dai, Jun; Yu, Maoxing; Li, Jianqing; Shen, Pjngchuan; Hu, Rong; Lou, Xiaoding; Zhao, Zujin*; Tang, Ben ZhongChemical Science, 2020, 11(13): 3405-3417.被引 164
  • Amplifying Free Radical Generation of AIE Photosensitizer with Small Singlet-Triplet Splitting for Hypoxia-Overcoming Photodynamic Therapy
    Xiao, Ya-Fang; Chen, Wen-Cheng; Chen, Jia-Xiong; Lu, Guihong*; Tian, Shuang; Cui, Xiao; Zhang, Zhen; Chen, Huan; Wan, Yingpeng; Li, Shengliang*; Lee, Chun-Sing*ACS applied materials & interfaces, 2022, 14(4): 5112-5121.被引 37
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Materials Chemistry B
发表日期
2023-05-31
卷期
第 11 卷, 第 21 期
页码
4600-4618
DOI
10.1039/d3tb00545c
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22071065]; Natural Science Foundation of Guangdong Province [2022A1515011743]

作者

  • L

    Lu, Bingli (第一作者)

  • W

    Wang, Lingyun (通讯)

查看全部 4 位作者收起作者
  • T

    Tang, Hao

  • C

    Cao, Derong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417